Has Diane Sobkowicz, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,608 in general payments to Diane Sobkowicz, MD across 36 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Diane Sobkowicz, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Diane Sobkowicz, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Diane Sobkowicz, MD

Cardiovascular Disease · Auburn, CANPI 1285739698

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.2% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Abbott at 37.2% of the total. Reporting peaked in 2019 at $556 and has fallen 88.9% since, to $62 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in CA, where the typical reported total is $2,142.

$1,608in general payments, 2019–2025

Across 36 payments — averaging $44.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$598
Amgen$252
Novartis$249
Medtronic$226
Sanofi-aventis U.S. LLC$100
Boston Scientific$96
plus $87 from 2 others

What the payments were for

Food & beverage$1,59699%
Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	11	$598
Amgen	4	$252
Novartis	2	$249
Medtronic(2 entities)	11	$226
Sanofi-aventis U.S. LLC	1	$100
Boston Scientific	3	$96
Amarin Pharma, Inc.	2	$49
Regeneron Healthcare Solutions, Inc.	2	$38

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,608 in reported general payments places this provider in the 45th percentile of 2,184 cardiovascular disease providers in California.

See all cardiovascular disease providers in California →

Medicare billing

Part B allowed, 2024

$322,661

Medicare patients

2,611

Services billed

4,812

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Repatha SureclickEvolocumab	766	$996,827
Praluent PenAlirocumab	187	$205,828
EliquisApixaban	84	$109,832
NexletolBempedoic Acid	63	$46,183
VascepaIcosapent Ethyl	45	$34,599
Ezetimibe	1,246	$29,377
XareltoRivaroxaban	13	$20,902
Rosuvastatin Calcium	1,155	$19,264
Omega-3 Acid Ethyl Esters	137	$12,204
Icosapent Ethyl	29	$7,738
Atorvastatin Calcium	345	$4,367
Niacin ErNiacin	49	$3,725
Metoprolol Succinate	102	$2,040
Candesartan Cilexetil	14	$1,903
Valsartan	24	$1,486

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Auburn

Ted LoveHillsborough$102.8M
Paul KurthSanta Barbara$6.1M
Jason RogersSacramento$4.4M
Matthew BudoffTorrance$3.6M
Eric Topolla Jolla$2.2M
Cathleen Bairey-MerzLos Angeles$1.2M
Gagan SinghSacramento$1.2M
Pam Taubla Jolla$1.2M
Wilber SuStanford$1.1M
Thomas SmithSacramento$942K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →